Health Care, HIPAA, and Telemedicine Law

HB Ad Slot
HB Mobile Ad Slot

Healthcare law is constantly changing, especially in today’s data driven online world.  Healthcare providers have unprecedented concerns related to privacy and cybersecurity as different technologies and threats intersect in ways never seen before.  With the growth of cloud computing and electronic health records, more regulations and greater scrutiny has been given to the industry, as hospitals, medical providers and healthcare agencies are liable in new and different ways.

The National Law Review covers all legal aspects of the healthcare industry, with expert legal analysis on HIPAA regulations, non-profit organization status, to home health and nursing care abuse.   Additionally, the National Law Review covered all aspects of the Affordable Care Act, or Obamacare, and its implementation, as well as the various attempts to repeal the ACA and new legislation in the healthcare arena, including the American Health Care Act of 2017.

Visitors can read about the US Department of Health and Human Services (HHS), the Office for Civil Rights (OCR), and regulations being promulgated by the Food and Drug Administration (FDA). The Center for Medicare & Medicaid Services (CMS) is also frequently discussed as it relates to drug pricing plans and premiums, new insurance policy requirements and other industry norms.

A major issue in healthcare is the prominence of Ransomware attacks and other cybersecurity concerns, as they relate to patient protected information and HIPAA compliance.  Healthcare systems wanting to maintain compliance with HIPAA regulations and protect patient privacy can find legal analysis and information on how to do so.

Additionally, the rise of Telehealth initiatives in a variety of areas is another area covered by the National Law Review.  With these new technologies, there is a lot of opportunity for innovation, however, careful understanding of telehealth legislation, reimbursement policies and regulations is essential to maintain a standard of care and avoid litigation.

Hospice care, the opioid epidemic, Medicare reimbursement, and issues with antitrust when healthcare systems merge are among the news stories covered by the National Law Review.  Visitors will consistently find updated stories on regulating medical devices, new life sciences technologies, and legislative developments in the healthcare arena. Because the industry is ever-changing, the National Law Review always has new content related to healthcare law.

National Law Review Healthcare Law XFor hourly updates in the latest news about Healthcare & Health Management law, regulations, and legislation, be sure to follow our Health Law X (formerly Twitter) feed, and sign up here for our daily complimentary e-news bulletins.

Recent Health Care, Medicare, ACA, HIPAA & OIG Law News

Title
Custom text Organization
Nov
2
2023
Rare DOJ Criminal Indictment Related to Medicare Advantage Risk Adjustment Epstein Becker & Green, P.C.
Nov
2
2023
HHS-OIG Issues Unfavorable Opinion Saying Offering Free Hearing Aid With Cochlear Implant Presents Risk Of Fraud, Abuse Barnes & Thornburg LLP
Nov
2
2023
CMS Announces 0.8 Percent Aggregate Home Health Payment Increase in 2024 Robinson & Cole LLP
Nov
2
2023
Competition Currents | November 2023 Greenberg Traurig, LLP
Nov
2
2023
2024 Cost of Living Adjustments Varnum LLP
Nov
2
2023
The PACE Solution to Increasing Demands for Long-Term Services and Supports in the U.S. Sheppard, Mullin, Richter & Hampton LLP
Nov
2
2023
Attention! Important New Decision on Accrual of Paid Leave in France Squire Patton Boggs (US) LLP
Nov
2
2023
Diagnosing Health Care Podcast – Episode 71: Dietary Supplements – Navigating the Regulatory Maze [Podcast] Epstein Becker & Green, P.C.
Nov
1
2023
Landmark Executive Order on AI: What Does it Mean for Healthcare? McDermott Will & Emery
Nov
1
2023
IRS Announces 2024 Employee Benefit Plan Limits McDermott Will & Emery
Nov
1
2023
Hospital Mergers: The Value and Pitfalls Sheppard, Mullin, Richter & Hampton LLP
Nov
1
2023
The Increasing Trend of Chinese Asylum-Seekers at the US Border Norris McLaughlin P.A.
Nov
1
2023
OIG Issues Unfavorable Advisory Opinion on Free Items to Patients Tied to Reimbursable Services Mintz
Nov
1
2023
HHS Proposes Disincentives for Providers that Commit Information Blocking Robinson & Cole LLP
Nov
1
2023
White House Executive Order on Artificial Intelligence: Implications for the Health Care and Life Sciences Industries Epstein Becker & Green, P.C.
Oct
31
2023
Options for Menopause Benefits for Employees Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
31
2023
CMS Announces New Guide Model for People Living with Dementia and Their Caregivers McDermott Will & Emery
Oct
31
2023
Significant Changes to Massachusetts Paid Family Leave Coming on November 1, 2023 ArentFox Schiff LLP
Oct
31
2023
Safety Perspectives From Region 6: Tales and Lessons From the Field Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
31
2023
California Takes Steps Towards a Unified Health Care Financing System Squire Patton Boggs (US) LLP
Oct
31
2023
Top Takeaways | 2023 PPM-ASC Symposium | Specialty Spotlight: Behavioral Health McDermott Will & Emery
Oct
31
2023
FDA: New Draft Guidance on Communication of Unapproved Uses of Approved or Cleared Medical Products Foley & Lardner LLP
Oct
31
2023
Massachusetts Department of Paid Family and Medical Leave Revises Guidance on Topping Off Benefits With Accrued Paid Leave Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
30
2023
Healthcare Preview for the Week of: October 30, 2023 McDermott Will & Emery
Oct
30
2023
Guidance from FDA Clarifies a Key Issue for Industry: Non-Promotional Presentations About Unapproved Uses of Medical Products Can Be Produced by the Products’ Sponsors Without Violating Off-Label Rules Mintz
Oct
30
2023
Don’t Leave Money on the Table from Your Pandemic-Era Healthcare Procurement Contract Sheppard, Mullin, Richter & Hampton LLP
Oct
30
2023
Fast 5: Five Quick Regulatory Takeaways for Pharmaceutical Companies ArentFox Schiff LLP
Oct
30
2023
District of Massachusetts Split on Causation Standard in Kickback FCA Cases Bradley Arant Boult Cummings LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins